| Mark Iwicki | Chief Executive Officer and Director | FY2025 | |
| Chris Cabell, M.D. | President and Head of Research and Development | FY2025 | |
| David McIntyre | Chief Financial Officer | FY2025 | |
| Milton H. Werner, Ph.D. | Former President and Chief Executive Officer | FY2025 |
4 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.